Strattera and Gamma-glutamyltransferase increased - a phase IV clinical study of FDA data

Summary:

Gamma-glutamyltransferase increased is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for 1 - 6 months also take Lexapro, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Gamma-glutamyltransferase increased when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Gamma-glutamyltransferase increased?

Gamma-glutamyltransferase increased is found to be associated with 1,344 drugs and 2,167 conditions by eHealthMe. Check the latest studies of Gamma-glutamyltransferase increased.

On Jul, 17, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 47 people (0.17%) have Gamma-glutamyltransferase increased.

Could Strattera cause Gamma-glutamyltransferase increased?

Among these 47 people:

How long have people been on Strattera when they have Gamma-glutamyltransferase increased? *

What is the gender of people who have Gamma-glutamyltransferase increased when taking Strattera? *

female: 21.74 %
male: 78.26 %

What is the age of people who have Gamma-glutamyltransferase increased when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Gamma-glutamyltransferase increased? *

Alanine Aminotransferase Increased: 42 people, 89.36%
Aspartate Aminotransferase Increased: 37 people, 78.72%
Blood Alkaline Phosphatase Increased: 14 people, 29.79%
Nausea (feeling of having an urge to vomit): 13 people, 27.66%
Blood Bilirubin Increased: 9 people, 19.15%
Nausea And Vomiting: 8 people, 17.02%
Weakness: 6 people, 12.77%
Head Injury: 5 people, 10.64%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 5 people, 10.64%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 10.64%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 5 people, 10.64%
Adjustment Disorder: 2 people, 4.26%
Post-Traumatic Stress Disorder: 2 people, 4.26%
Insomnia (sleeplessness): 2 people, 4.26%
Affect Lability (emotional incontinence): 1 person, 2.13%
Anaemia (lack of blood): 1 person, 2.13%
Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 2.13%
Constipation: 1 person, 2.13%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 2.13%
Stress And Anxiety: 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Gamma-glutamyltransferase increased?

- Check whether Gamma-glutamyltransferase increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gamma-glutamyltransferase increased:

Gamma-glutamyltransferase increased (1,344 drugs)

Browse all the conditions that are associated with Gamma-glutamyltransferase increased:

Gamma-glutamyltransferase increased (2,167 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.